An IAEA expert mission was deployed to Suva, Fiji, to support the recovery and transportation of radium-226 to the USA, where the sources will be used as a feedstock to produce actinium-225, an ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Indian researchers have made a significant leap in the treatment of Rheumatoid Arthritis (RA) with a revolutionary “self-actuating” drug delivery system. This cutting-edge approach aims to ...

Currently, RA treatments primarily involve systemic drug administration, where medication circulates throughout the body. While effective in controlling inflammation, this approach has several ...

The positive trial results have not only demonstrated rosnilimab's potential in treating RA but have also validated AnaptysBio's scientific approach in targeting PD-1 co-inhibitory receptors on ...

Evan Y. Yu, MD, discusses the safety data from the phase 3 PEACE-3 study of enzalutamide (ENZA) combined with radium-223 ...

Greater weight loss was linked to lower discontinuation rates, with a 1% reduction in weight lowering the hazard of ...

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...

Getting diagnosed and starting treatment early can help minimize symptoms, slow the progression of the disease, and improve long-term quality of life. In the early stages of RA, the immune system ...

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.